You are here

Article Text

Article menu
Research letter
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
Free
  1. Gregory J Keir,
  2. Benjamin Garfield,
  3. David M Hansell,
  4. Michael R Loebinger,
  5. Robert Wilson,
  6. Elisabetta A Renzoni,
  7. Athol U Wells,
  8. Toby M Maher
  1. Royal Brompton Hospital, London, UK
  1. Correspondence to Dr Toby M Maher, Interstitial Lung Disease Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; t.maher{at}rbht.nhs.uk

Abstract

Abstract In sarcoidosis, chronic pulmonary aspergillosis (CPA) may be associated with significant morbidity, and treatment failure rates are often high, even with newer triazole antifungal agents. We report a treatment regimen of cyclical caspofungin infusions in 10 patients with sarcoidosis and worsening CPA despite oral triazoles.

  • Sarcoidosis
  • Aspergillus Lung Disease

https://doi.org/10.1136/thoraxjnl-2013-203988

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Supplementary materials

    • Supplementary Data

      This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

      Files in this Data Supplement: